Cargando…

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to several observations, agitation prevalence ranges from 30 to 50% in Alzheimer's disease, 30% in dementia with Lewy bodies, 40% in f...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrarini, Claudia, Russo, Mirella, Dono, Fedele, Barbone, Filomena, Rispoli, Marianna G., Ferri, Laura, Di Pietro, Martina, Digiovanni, Anna, Ajdinaj, Paola, Speranza, Rino, Granzotto, Alberto, Frazzini, Valerio, Thomas, Astrid, Pilotto, Andrea, Padovani, Alessandro, Onofrj, Marco, Sensi, Stefano L., Bonanni, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085397/
https://www.ncbi.nlm.nih.gov/pubmed/33935943
http://dx.doi.org/10.3389/fneur.2021.644317
_version_ 1783686330876690432
author Carrarini, Claudia
Russo, Mirella
Dono, Fedele
Barbone, Filomena
Rispoli, Marianna G.
Ferri, Laura
Di Pietro, Martina
Digiovanni, Anna
Ajdinaj, Paola
Speranza, Rino
Granzotto, Alberto
Frazzini, Valerio
Thomas, Astrid
Pilotto, Andrea
Padovani, Alessandro
Onofrj, Marco
Sensi, Stefano L.
Bonanni, Laura
author_facet Carrarini, Claudia
Russo, Mirella
Dono, Fedele
Barbone, Filomena
Rispoli, Marianna G.
Ferri, Laura
Di Pietro, Martina
Digiovanni, Anna
Ajdinaj, Paola
Speranza, Rino
Granzotto, Alberto
Frazzini, Valerio
Thomas, Astrid
Pilotto, Andrea
Padovani, Alessandro
Onofrj, Marco
Sensi, Stefano L.
Bonanni, Laura
author_sort Carrarini, Claudia
collection PubMed
description Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to several observations, agitation prevalence ranges from 30 to 50% in Alzheimer's disease, 30% in dementia with Lewy bodies, 40% in frontotemporal dementia, and 40% in vascular dementia (VaD). With an overall prevalence of about 30%, agitation is the third most common neuropsychiatric symptoms (NPS) in dementia, after apathy and depression, and it is even more frequent (80%) in residents of nursing homes. The pathophysiological mechanism underlying agitation is represented by a frontal lobe dysfunction, mostly involving the anterior cingulate cortex (ACC) and the orbitofrontal cortex (OFC), respectively, meaningful in selecting the salient stimuli and subsequent decision-making and behavioral reactions. Furthermore, increased sensitivity to noradrenergic signaling has been observed, possibly due to a frontal lobe up-regulation of adrenergic receptors, as a reaction to the depletion of noradrenergic neurons within the locus coeruleus (LC). Indeed, LC neurons mainly project toward the OFC and ACC. These observations may explain the abnormal reactivity to weak stimuli and the global arousal found in many patients who have dementia. Furthermore, agitation can be precipitated by several factors, e.g., the sunset or low lighted environments as in the sundown syndrome, hospitalization, the admission to nursing residencies, or changes in pharmacological regimens. In recent days, the global pandemic has increased agitation incidence among dementia patients and generated higher distress levels in patients and caregivers. Hence, given the increasing presence of this condition and its related burden on society and the health system, the present point of view aims at providing an extensive guide to facilitate the identification, prevention, and management of acute and chronic agitation in dementia patients.
format Online
Article
Text
id pubmed-8085397
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80853972021-05-01 Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions Carrarini, Claudia Russo, Mirella Dono, Fedele Barbone, Filomena Rispoli, Marianna G. Ferri, Laura Di Pietro, Martina Digiovanni, Anna Ajdinaj, Paola Speranza, Rino Granzotto, Alberto Frazzini, Valerio Thomas, Astrid Pilotto, Andrea Padovani, Alessandro Onofrj, Marco Sensi, Stefano L. Bonanni, Laura Front Neurol Neurology Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to several observations, agitation prevalence ranges from 30 to 50% in Alzheimer's disease, 30% in dementia with Lewy bodies, 40% in frontotemporal dementia, and 40% in vascular dementia (VaD). With an overall prevalence of about 30%, agitation is the third most common neuropsychiatric symptoms (NPS) in dementia, after apathy and depression, and it is even more frequent (80%) in residents of nursing homes. The pathophysiological mechanism underlying agitation is represented by a frontal lobe dysfunction, mostly involving the anterior cingulate cortex (ACC) and the orbitofrontal cortex (OFC), respectively, meaningful in selecting the salient stimuli and subsequent decision-making and behavioral reactions. Furthermore, increased sensitivity to noradrenergic signaling has been observed, possibly due to a frontal lobe up-regulation of adrenergic receptors, as a reaction to the depletion of noradrenergic neurons within the locus coeruleus (LC). Indeed, LC neurons mainly project toward the OFC and ACC. These observations may explain the abnormal reactivity to weak stimuli and the global arousal found in many patients who have dementia. Furthermore, agitation can be precipitated by several factors, e.g., the sunset or low lighted environments as in the sundown syndrome, hospitalization, the admission to nursing residencies, or changes in pharmacological regimens. In recent days, the global pandemic has increased agitation incidence among dementia patients and generated higher distress levels in patients and caregivers. Hence, given the increasing presence of this condition and its related burden on society and the health system, the present point of view aims at providing an extensive guide to facilitate the identification, prevention, and management of acute and chronic agitation in dementia patients. Frontiers Media S.A. 2021-04-16 /pmc/articles/PMC8085397/ /pubmed/33935943 http://dx.doi.org/10.3389/fneur.2021.644317 Text en Copyright © 2021 Carrarini, Russo, Dono, Barbone, Rispoli, Ferri, Di Pietro, Digiovanni, Ajdinaj, Speranza, Granzotto, Frazzini, Thomas, Pilotto, Padovani, Onofrj, Sensi and Bonanni. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Carrarini, Claudia
Russo, Mirella
Dono, Fedele
Barbone, Filomena
Rispoli, Marianna G.
Ferri, Laura
Di Pietro, Martina
Digiovanni, Anna
Ajdinaj, Paola
Speranza, Rino
Granzotto, Alberto
Frazzini, Valerio
Thomas, Astrid
Pilotto, Andrea
Padovani, Alessandro
Onofrj, Marco
Sensi, Stefano L.
Bonanni, Laura
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_full Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_fullStr Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_full_unstemmed Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_short Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_sort agitation and dementia: prevention and treatment strategies in acute and chronic conditions
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085397/
https://www.ncbi.nlm.nih.gov/pubmed/33935943
http://dx.doi.org/10.3389/fneur.2021.644317
work_keys_str_mv AT carrariniclaudia agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT russomirella agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT donofedele agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT barbonefilomena agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT rispolimariannag agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT ferrilaura agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT dipietromartina agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT digiovannianna agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT ajdinajpaola agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT speranzarino agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT granzottoalberto agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT frazzinivalerio agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT thomasastrid agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT pilottoandrea agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT padovanialessandro agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT onofrjmarco agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT sensistefanol agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT bonannilaura agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions